<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Tue, 28 Apr 2026 09:35:35 -0400--><rss version="2.0">
    <channel>
        <title>Inhibitor Therapeutics, Inc. (INTI) SEC Filings</title>
        <link>https://investors.inhibitortx.com/sec-filings/section-16-filings/rss</link>
        <description>Inhibitor Therapeutics, Inc. (INTI) - Section 16 Filings</description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/_5a8cb0b9c83c9803ac6e80d95e72f0b2/inhibitortx/files/theme/images/logo-sm.png</url>
                <title>Inhibitor Therapeutics, Inc. Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001641172-25-003556/0001641172-25-003556.pdf</link>
                <pubDate>Thu, 10 Apr 25 00:00:00 -0400</pubDate>
                <guid>https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001641172-25-003556/0001641172-25-003556.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001641172-25-003033/0001641172-25-003033.pdf</link>
                <pubDate>Mon, 07 Apr 25 00:00:00 -0400</pubDate>
                <guid>https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001641172-25-003033/0001641172-25-003033.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001641172-25-003029/0001641172-25-003029.pdf</link>
                <pubDate>Mon, 07 Apr 25 00:00:00 -0400</pubDate>
                <guid>https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001641172-25-003029/0001641172-25-003029.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001641172-25-003025/0001641172-25-003025.pdf</link>
                <pubDate>Mon, 07 Apr 25 00:00:00 -0400</pubDate>
                <guid>https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001641172-25-003025/0001641172-25-003025.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001641172-25-003023/0001641172-25-003023.pdf</link>
                <pubDate>Mon, 07 Apr 25 00:00:00 -0400</pubDate>
                <guid>https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001641172-25-003023/0001641172-25-003023.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[5 - Annual statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[5]]></description>
                <link>https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-25-007628/0001493152-25-007628.pdf</link>
                <pubDate>Wed, 19 Feb 25 00:00:00 -0500</pubDate>
                <guid>https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-25-007628/0001493152-25-007628.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[5 - Annual statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[5]]></description>
                <link>https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-25-007626/0001493152-25-007626.pdf</link>
                <pubDate>Wed, 19 Feb 25 00:00:00 -0500</pubDate>
                <guid>https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-25-007626/0001493152-25-007626.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-24-020173/0001493152-24-020173.pdf</link>
                <pubDate>Thu, 16 May 24 00:00:00 -0400</pubDate>
                <guid>https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-24-020173/0001493152-24-020173.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-24-020171/0001493152-24-020171.pdf</link>
                <pubDate>Thu, 16 May 24 00:00:00 -0400</pubDate>
                <guid>https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-24-020171/0001493152-24-020171.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-24-020172/0001493152-24-020172.pdf</link>
                <pubDate>Thu, 16 May 24 00:00:00 -0400</pubDate>
                <guid>https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-24-020172/0001493152-24-020172.pdf</guid>
                                                                            </item>
            </channel>
</rss>